CJC-1295 is a synthetic peptide belonging to the growth hormone releasing hormone (GHRH) analog class. It is designed for laboratory and scientific research applications focused on studying growth hormone secretion pathways, peptide stability, and endocrine system signaling mechanisms.

One of the key features of CJC-1295 is its extended half-life compared to standard GHRH analogs. This is achieved through its ability to bind to albumin, allowing for a more sustained release profile in controlled research settings. Because of this property, it is commonly used in experimental studies where prolonged GHRH activity is required for observation and analysis.

In research environments, CJC-1295 is often studied in combination with other peptides to evaluate synergistic effects on growth hormone pulsatility and receptor response. It is supplied in a lyophilized (freeze-dried) form to maintain stability and ensure consistent handling under laboratory conditions.

Key Research Characteristics:

• GHRH analog peptide
• Extended half-life due to albumin binding
• Used in endocrine and peptide signaling research
• Lyophilized powder for laboratory use
• Suitable for controlled in-vitro and research studies

Important Notice:
This product is intended strictly for laboratory research purposes only. It is not approved for human consumption, medical use, or veterinary use. Not for diagnosis, treatment, or prevention of any disease.